• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR® NEXT; QUALITY CONTROL MATERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR® NEXT; QUALITY CONTROL MATERIAL Back to Search Results
Model Number 7315
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/02/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The patient/family (a1) was the initial reporter (e1), so personal information was not entered.No information was captured in section a4 as the customer's weight was not provided.
 
Event or Problem Description
The customer contacted ascensia customer service to perform a control test with the contour® next one meter.With the assistance of the customer service agent, the customer ran a control test and obtained a reading of 71 mg/dl at 1:51 p.M.The meter did not automatically mark the control test, and so the reading will be displayed as a blood result when accessing the meter's memory.There was no allegation of an adverse event.The customer was advised to return the device for evaluation.Replacement meter kit and test strips were sent to the customer.
 
Additional Manufacturer Narrative
Despite follow-up attempts, the customer did not return the device for investigation.Therefore, an in-house testing was performed with the in-house contour® next one meter (serial # (b)(6)), in-house contour® next test strips (lot # 4gheg41a) and in-house contour® next control solution (lot # 4bv1a56) in five replicates.All tests recovered within the expected control range of 38 mg/dl to 48 mg/dl.The control results obtained with the in-house testing were properly marked as control tests in the meter.
 
Additional Manufacturer Narrative
The customer returned the contour® next one meter (serial # (b)(6), contour® next test strips (lot # 4jhec32a) and contour® next control solution (lot # 4bv1a56) for evaluation.The returned test strips were different from the lot associated with the event.An in-house testing was performed with the returned meter, test strips and control solution in five replicates.All tests recovered within the expected control range of 38 mg/dl to 48 mg/dl.The control results obtained with the in-house testing were properly marked as control tests in the meter.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR® NEXT
Common Device Name
QUALITY CONTROL MATERIAL
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
Manufacturer (Section G)
BIONOSTICS, INC. BUSINESS TRADE NAME: RNA MEDICAL
registration number: 1220649
7 jackson rd.
devens MA 01434
Manufacturer Contact
shweta gulati
100 summit lake drive
valhalla, NY 10595
9142361830
MDR Report Key22106372
Report Number1810909-2025-00081
Device Sequence Number7276179
Product Code JJX
UDI-Device Identifier10301937315012
UDI-Public(01)10301937315012(17)260228(10)4BV1A56
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K151742
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial,Followup,Followup
Report Date (Section B) 12/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date02/28/2026
Device Model Number7315
Device Catalogue Number83624826
Device Lot Number4BV1A56
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/02/2025
Supplement Date Received by Manufacturer09/03/2025
12/10/2025
Initial Report FDA Received Date05/29/2025
Supplement Report FDA Received Date09/08/2025
12/24/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/01/2024
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Patient Age83 YR
Patient SexMale
-
-